AMIX: AUTONOMIX MEDICAL INC Stocks News on July 27, 2024

Autonomix Completes Licensing Transaction for FDA-Cleared Ablation Technology

AMIX

GlobeNewswire

3 days ago

Autonomix Completes Licensing Transaction for FDA-Cleared Ablation Technology

AMIX

GlobeNewswire

4 days ago

Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series

AMIX

GlobeNewswire

9 days ago

Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor “What This Means” Segment Covering Technology License Agreement

Autonomix's Trial Results Show Meaningful Reduction In Pain For Patients Suffering From Pancreatic Cancer

AMIX

ACCESSWIRE

11 days ago

Autonomix's Trial Results Show Meaningful Reduction In Pain For Patients Suffering From Pancreatic Cancer

Autonomix Enters into Definitive Agreement to License Intellectual Property for FDA-Cleared Ablation Technology from RF Innovations, Inc.

AMIX

GlobeNewswire

12 days ago

Autonomix Enters into Definitive Agreement to License Intellectual Property for FDA-Cleared Ablation Technology from RF Innovations, Inc.

AMIX

GlobeNewswire

15 days ago

Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Launch of CEO Corner Platform

AMIX

GlobeNewswire

23 days ago

Autonomix Medical, Inc. (NASDAQ: AMIX) Reviews Positive Results Seen in Pancreatic Cancer Pain Trial in Virtual Investor “What This Means” Segment

Autonomix Announces Positive Topline Results from First Five Lead-In Patients in Ongoing Human Clinical Trial

AMIX

GlobeNewswire

a month ago

Autonomix Announces Positive Topline Results from First Five Lead-In Patients in Ongoing Human Clinical Trial

Autonomix Enhances Executive Leadership Team with Appointment of Proven Medical Technology Leader, Brad Hauser, as President and Chief Executive Officer

AMIX

GlobeNewswire

a month ago

Autonomix Enhances Executive Leadership Team with Appointment of Proven Medical Technology Leader, Brad Hauser, as President and Chief Executive Officer

Autonomix to Announce Preliminary Topline Results from First Five Lead-In Patients in Ongoing Human Clinical Trial on June 18, 2024

AMIX

GlobeNewswire

2 months ago

Autonomix to Announce Preliminary Topline Results from First Five Lead-In Patients in Ongoing Human Clinical Trial on June 18, 2024

This One Company Is Working On A Breakthrough Approach To Revolutionize Pain Management

AMIX

ACCESSWIRE

2 months ago

This One Company Is Working On A Breakthrough Approach To Revolutionize Pain Management

Autonomix Announces Approval of Protocol Amendment by Ethics Committee Upon Completion of All Lead-In Patients in Ongoing Human Clinical Trial

AMIX

GlobeNewswire

2 months ago

Autonomix Announces Approval of Protocol Amendment by Ethics Committee Upon Completion of All Lead-In Patients in Ongoing Human Clinical Trial

Autonomix Medical, Inc. Reports Full Year 2024 Financial Results and Provides Corporate Update

AMIX

GlobeNewswire

2 months ago

Autonomix Medical, Inc. Reports Full Year 2024 Financial Results and Provides Corporate Update

Autonomix Preclinical Study Successfully Demonstrates That Nerve Ablation Can Slow Tumor Metastasis in Pancreatic Cancer

AMIX

GlobeNewswire

2 months ago

Autonomix Preclinical Study Successfully Demonstrates That Nerve Ablation Can Slow Tumor Metastasis in Pancreatic Cancer

AMIX

GlobeNewswire

2 months ago

Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series

Autonomix Enters into Agreement with NoiseFigure Research, Inc. to Develop Next Generation of its Proprietary Microchip

AMIX

GlobeNewswire

3 months ago

Autonomix Enters into Agreement with NoiseFigure Research, Inc. to Develop Next Generation of its Proprietary Microchip

Autonomix to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar

AMIX

GlobeNewswire

3 months ago

Autonomix to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar

Autonomix Announces Issuance of U.S. Patent Covering Proprietary Catheter-Based Technology for the Treatment of Cancer Related Pain

AMIX

GlobeNewswire

3 months ago

Autonomix Announces Issuance of U.S. Patent Covering Proprietary Catheter-Based Technology for the Treatment of Cancer Related Pain

Autonomix Medical Inc. Covered in Benzinga Article Highlighting Innovative Nerve Treatment Technology

AMIX

News Direct

3 months ago

Autonomix Medical Inc. Covered in Benzinga Article Highlighting Innovative Nerve Treatment Technology

Autonomix Announces Positive Findings from Preclinical Study Demonstrating Potential to Improve Renal Denervation

AMIX

GlobeNewswire

4 months ago

Autonomix Announces Positive Findings from Preclinical Study Demonstrating Potential to Improve Renal Denervation

AMIX

GlobeNewswire

4 months ago

Autonomix to Participate in the Virtual Investor Lunch Break: The Team Behind the AMIX Ticker

Autonomix to Present at the MedInvest Biotech & Pharma Investor Conference

AMIX

GlobeNewswire

4 months ago

Autonomix to Present at the MedInvest Biotech & Pharma Investor Conference

AMIX

GlobeNewswire

4 months ago

Autonomix (NASDAQ: AMIX) to Present at the Benzinga Virtual Healthcare Summit 2024

Autonomix Appoints Jennifer Cook as Chief Business Officer

AMIX

GlobeNewswire

4 months ago

Autonomix Appoints Jennifer Cook as Chief Business Officer

Autonomix Completes First Three Patient Procedures in Human Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer Market

AMIX

GlobeNewswire

4 months ago

Autonomix Completes First Three Patient Procedures in Human Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer Market

Autonomix Enrolls First Patients in Human Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer Market

AMIX

GlobeNewswire

5 months ago

Autonomix Enrolls First Patients in Human Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer Market

Autonomix Signs Key Clinical Agreements in Preparation to Begin March 2024 Human Clinical Trial

AMIX

GlobeNewswire

5 months ago

Autonomix Signs Key Clinical Agreements in Preparation to Begin March 2024 Human Clinical Trial

AMIX

GlobeNewswire

5 months ago

Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Lunch Break: The Autonomix Opportunity

Autonomix Secures Principal Investigators and Completes Clinical Training for First Human Study

AMIX

GlobeNewswire

5 months ago

Autonomix Secures Principal Investigators and Completes Clinical Training for First Human Study

Autonomix Begins Human POC Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer Market

AMIX

GlobeNewswire

5 months ago

Autonomix Begins Human POC Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer Market

Autonomix Medical, Inc. Reports Third Quarter FY2024 Financial Results and Reiterates Upcoming Key Milestones

AMIX

GlobeNewswire

5 months ago

Autonomix Medical, Inc. Reports Third Quarter FY2024 Financial Results and Reiterates Upcoming Key Milestones

AMIX

ACCESSWIRE

6 months ago

Autonomix Medical, Inc. (NASDAQ:AMIX) to Present at Integrous Big Hearts, Big Ideas Virtual Investor Conference

Autonomix Medical, Inc. Receives Ethics Committee Authorization for Proof-of-Concept Human Clinical Study Evaluating Proprietary Ablation Technology for Treatment of Pancreatic Cancer Pain

AMIX

GlobeNewswire

6 months ago

Autonomix Medical, Inc. Receives Ethics Committee Authorization for Proof-of-Concept Human Clinical Study Evaluating Proprietary Ablation Technology for Treatment of Pancreatic Cancer Pain

AMIX

GlobeNewswire

6 months ago

Autonomix Medical, Inc. (NASDAQ: AMIX) to Present at the Virtual Investor New to the Street Event

Autonomix Medical, Inc. to Ring the Nasdaq Stock Market Closing Bell on Thursday, February 1, 2024

AMIX

GlobeNewswire

6 months ago

Autonomix Medical, Inc. to Ring the Nasdaq Stock Market Closing Bell on Thursday, February 1, 2024

Autonomix Medical, Inc. Completes $8,000,000 Transaction for Exclusive Worldwide Rights to Technology for Cardiology Field Use – Over 100 patents in portfolio

AMIX

GlobeNewswire

6 months ago

Autonomix Medical, Inc. Completes $8,000,000 Transaction for Exclusive Worldwide Rights to Technology for Cardiology Field Use – Over 100 patents in portfolio

Autonomix Medical, Inc. Completes Transaction for Exclusive Worldwide Rights to Technology for Cardiology Field Use

AMIX

GlobeNewswire

6 months ago

Autonomix Medical, Inc. Completes Transaction for Exclusive Worldwide Rights to Technology for Cardiology Field Use

AMIX

GlobeNewswire

6 months ago

Latest AUTONOMIX MEDICAL INC (AMIX) News on July 27, 2024

Autonomix Completes Licensing Transaction for FDA-Cleared Ablation Technology

Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series

Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor “What This Means” Segment Covering Technology License Agreement

Autonomix's Trial Results Show Meaningful Reduction In Pain For Patients Suffering From Pancreatic Cancer

Autonomix Enters into Definitive Agreement to License Intellectual Property for FDA-Cleared Ablation Technology from RF Innovations, Inc.

Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Launch of CEO Corner Platform

Autonomix Medical, Inc. (NASDAQ: AMIX) Reviews Positive Results Seen in Pancreatic Cancer Pain Trial in Virtual Investor “What This Means” Segment

Autonomix Announces Positive Topline Results from First Five Lead-In Patients in Ongoing Human Clinical Trial

Autonomix Enhances Executive Leadership Team with Appointment of Proven Medical Technology Leader, Brad Hauser, as President and Chief Executive Officer

Autonomix to Announce Preliminary Topline Results from First Five Lead-In Patients in Ongoing Human Clinical Trial on June 18, 2024

This One Company Is Working On A Breakthrough Approach To Revolutionize Pain Management

Autonomix Announces Approval of Protocol Amendment by Ethics Committee Upon Completion of All Lead-In Patients in Ongoing Human Clinical Trial

Autonomix Medical, Inc. Reports Full Year 2024 Financial Results and Provides Corporate Update

Autonomix Preclinical Study Successfully Demonstrates That Nerve Ablation Can Slow Tumor Metastasis in Pancreatic Cancer

Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series

Autonomix Enters into Agreement with NoiseFigure Research, Inc. to Develop Next Generation of its Proprietary Microchip

Autonomix to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar

Autonomix Announces Issuance of U.S. Patent Covering Proprietary Catheter-Based Technology for the Treatment of Cancer Related Pain

Autonomix Medical Inc. Covered in Benzinga Article Highlighting Innovative Nerve Treatment Technology

Autonomix Announces Positive Findings from Preclinical Study Demonstrating Potential to Improve Renal Denervation

Autonomix to Participate in the Virtual Investor Lunch Break: The Team Behind the AMIX Ticker

Autonomix to Present at the MedInvest Biotech & Pharma Investor Conference

Autonomix (NASDAQ: AMIX) to Present at the Benzinga Virtual Healthcare Summit 2024

Autonomix Appoints Jennifer Cook as Chief Business Officer

Autonomix Completes First Three Patient Procedures in Human Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer Market

Autonomix Enrolls First Patients in Human Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer Market

Autonomix Signs Key Clinical Agreements in Preparation to Begin March 2024 Human Clinical Trial

Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Lunch Break: The Autonomix Opportunity

Autonomix Secures Principal Investigators and Completes Clinical Training for First Human Study

Autonomix Begins Human POC Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer Market

Autonomix Medical, Inc. Reports Third Quarter FY2024 Financial Results and Reiterates Upcoming Key Milestones

Autonomix Medical, Inc. (NASDAQ:AMIX) to Present at Integrous Big Hearts, Big Ideas Virtual Investor Conference

Autonomix Medical, Inc. Receives Ethics Committee Authorization for Proof-of-Concept Human Clinical Study Evaluating Proprietary Ablation Technology for Treatment of Pancreatic Cancer Pain

Autonomix Medical, Inc. (NASDAQ: AMIX) to Present at the Virtual Investor New to the Street Event

Autonomix Medical, Inc. to Ring the Nasdaq Stock Market Closing Bell on Thursday, February 1, 2024

Autonomix Medical, Inc. Completes $8,000,000 Transaction for Exclusive Worldwide Rights to Technology for Cardiology Field Use – Over 100 patents in portfolio

Autonomix Medical, Inc. Completes Transaction for Exclusive Worldwide Rights to Technology for Cardiology Field Use

Autonomix Medical, Inc. (NASDAQ: AMIX) Commences Trading on NASDAQ

Share on Social Networks: